Publications by authors named "Kelly Goldsmith"

Claim this Profile
A
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum.
Steven G DuBois, Lucas Moreno, John Anderson, Shahab Asgharzadeh, Ro Bagatell, Kelly C Goldsmith

Pediatr Blood Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.
Thomas Cash, Araz Marachelian, Steven G DuBois, Yueh-Yun Chi, Anahit Baregamyan, Kelly C Goldsmith

J Clin Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid Leukaemia.
Seth E Karol, Seong L Khaw, C Michel Zwaan, Andre Baruchel, Henrique Bittencourt, Kelly C Goldsmith

Pediatr Blood Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for 3D bioprinting of a 3D in vitro model of neuroblastoma.
Mehdi Salar Amoli, Sarah Rezapourdamanab, Linqi Jin, Melissa A Cadena, Kaveeta Kaw, Kelly C Goldsmith

STAR Protoc· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in analgesia-sedation of pediatric patients receiving I-131 MIBG in the pediatric intensive care unit: A report from the Pediatric Health Information System database.
Jordann Dhuse, Thomas Cash, Michael S Elges, Adina Alazraki, Rachael Beer, Kelly C Goldsmith

Pediatr Blood Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and Emerging Biomarkers: Impact on Risk Stratification for Neuroblastoma.
Meredith S Irwin, Kelly C Goldsmith

J Natl Compr Canc Netw· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin.
Karuna Mittal, Garrett W Cooper, Benjamin P Lee, Yongdong Su, Katie T Skinner, Kelly C Goldsmith

Commun Biol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Children's Oncology Group's 2023 blueprint for research: Neuroblastoma.
Rochelle Bagatell, Steven G DuBois, Arlene Naranjo, Jen Belle, Kelly C Goldsmith

Pediatr Blood Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors.
Thomas Cash, Hunter C Jonus, Maya Tsvetkova, Jan H Beumer, Arhanti Sadanand, Kelly C Goldsmith

Pediatr Blood Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of .
Adeiye A Pilgrim, Hunter C Jonus, Andrew Ho, Anna C Cole, Jenny Shim, Kelly C Goldsmith

Oncoimmunology· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma.
Jasmine Y Lee, Hunter C Jonus, Arhanti Sadanand, Gianna M Branella, Victor Maximov, Kelly C Goldsmith

Cell Rep Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the role of scarcity in marketing: Identifying research opportunities across the 5Ps.
Caroline Roux, Kelly Goldsmith, Christopher Cannon

J Acad Mark Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results.
Kelly C Goldsmith, Julie R Park, Kimberly Kayser, Jemily Malvar, Yueh-Yun Chi

Nat Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma.
Esther R Berko, Gabriela M Witek, Smita Matkar, Zaritza O Petrova, Megan A Wu, Kelly C Goldsmith

Nat Commun· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a Novel Fusion with Targeted Therapeutic Implications in Locally Advanced Pediatric Cholangiocarcinoma: A Case Report.
Sarah G Mitchell, Gargi D Basu, Bree Eaton, Laurie J Goodman, Kelly C Goldsmith

Case Rep Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De-stigmatizing the "win-win:" making sustainable consumption sustainable.
Kelly Goldsmith, Caroline Roux, Ali Tezer, Christopher Cannon

Curr Opin Psychol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 3D Bioprinted in vitro Model of Neuroblastoma Recapitulates Dynamic Tumor-Endothelial Cell Interactions Contributing to Solid Tumor Aggressive Behavior.
Liqun Ning, Jenny Shim, Martin L Tomov, Rui Liu, Riya Mehta, Kelly C Goldsmith

Adv Sci (Weinh)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced ER-mitochondria connectivity promotes neuroblastoma multidrug resistance.
Jorida Çoku, David M Booth, Jan Skoda, Madison C Pedrotty, Jennifer Vogel, Kelly C Goldsmith

EMBO J· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissecting the cellular components of γδ T cell expansions to optimize selection of potent cell therapy donors for neuroblastoma immunotherapy trials.
Hunter C Jonus, Rebecca E Burnham, Andrew Ho, Adeiye A Pilgrim, Jenny Shim, Kelly C Goldsmith

Oncoimmunology· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical Care.
Ryan J Summers, Sharon M Castellino, Christopher C Porter, Tobey J MacDonald, Gargi D Basu, Kelly C Goldsmith

JCO Precis Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium.
Steven G DuBois, M Meaghan Granger, Susan Groshen, Denice Tsao-Wei, Lingyun Ji, Kelly C Goldsmith

J Clin Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Player in Neuroblastoma: YAP and Its Role in the Neuroblastoma Microenvironment.
Jenny Shim, Kelly C Goldsmith

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the relationship between resource scarcity and object attachment.
Kelly Goldsmith, Caroline Roux, Christopher Cannon

Curr Opin Psychol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma Cells.
Lindy Vernooij, Laurel T Bate-Eya, Lindy K Alles, Jasmine Y Lee, Bianca Koopmans, Kelly C Goldsmith

Mol Cancer Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
YAP-Mediated Repression of HRK Regulates Tumor Growth, Therapy Response, and Survival Under Tumor Environmental Stress in Neuroblastoma.
Jenny Shim, Jasmine Y Lee, Hunter C Jonus, Amanda Arnold, Robert W Schnepp, Kelly C Goldsmith

Cancer Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis